Meningococcal Type B – A pharmacist’s guide to protecting patients against the most prevalent form of invasive meningococcal disease (IMD) in Canada


Upon successful completion of this continuing education program, the pharmacist will be better able to:

  1. Describe meningococcal disease burden, epidemiology, disease significance & severity
  2. Review the challenges to MenB vaccine development, the indications and modes of action
  3. Highlight the growing body of scientific evidence supporting MenB vaccination e.g. real-world experience, dosing schedules, persistence data, immunogenicity data spanning the age cohorts at risk of disease
  4. Practical integration of non-publicly funded vaccines in the pharmacy: how to discuss MenB vaccination, targeting patients not seen as often by other healthcare professionals, practical vaccine administration considerations and how to address questions/concerns from parents/patients